Featured Research

from universities, journals, and other organizations

International efforts to combat rare metabolic disease

Date:
June 30, 2011
Source:
The Research Council of Norway
Summary:
The rare disorder alpha-mannosidosis can cause serious damage to the nervous system and other organ systems. Researchers believe a treatment may soon be available.

The rare disorder alpha-mannosidosis can cause serious damage to the nervous system and other organ systems. In Tromsø, Norway, researchers have been studying the disease for 20 years -- and a treatment may soon be available.

Related Articles


Alpha-mannosidosis is a rare, inherited metabolic disease causing mental retardation, serious skeletal and muscular abnormalities, and recurrent infections. It affects roughly one in 500 000 people.

The new treatment is based on supplementing alpha-mannosidase, the enzyme which is deficient or does not function properly in people born with the disorder, explains Professor Øivind Nilssen of the Department of Medical Genetics under the Institute of Clinical Medicine at the University of Tromsø.

The researchers in Tromsø were the first to characterise the alpha-mannosidosis gene, and have also supplied the alpha-mannosidase enzyme for therapy trials on animals.

Now Professor Nilssen's group is participating in its third EU project on this topic. If all goes well, clinical trials being held on patients in Denmark could lead to a treatment for the disease in four to five years.

At least 100 different mutations

The researchers in Tromsø have provided an important basis for developing the medication being tested. Collecting and analysing genetic materials from patients throughout Europe, the group has identified more than 100 different pathogenic mutations in over 170 families.

"Through our participation in the EU projects, we have continued working with these materials," says Professor Nilssen. "For example, we have created a database of mutations which contains clinical, demographic, genetic and biochemical data. Information about the patients taking part in the clinical trials is entered as well. By analysing this data we can predict how they will react to the treatment."

Treating the physical and mental symptoms

"We believe the treatment will improve the children's mental development, while in older patients the primary aim is to alleviate the suffering associated with bone disease and immune deficiency," concludes Professor Nilssen.


Story Source:

The above story is based on materials provided by The Research Council of Norway. Note: Materials may be edited for content and length.


Cite This Page:

The Research Council of Norway. "International efforts to combat rare metabolic disease." ScienceDaily. ScienceDaily, 30 June 2011. <www.sciencedaily.com/releases/2011/06/110630091659.htm>.
The Research Council of Norway. (2011, June 30). International efforts to combat rare metabolic disease. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2011/06/110630091659.htm
The Research Council of Norway. "International efforts to combat rare metabolic disease." ScienceDaily. www.sciencedaily.com/releases/2011/06/110630091659.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) — An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins